CatherineWeilerMDPhD, FACAAI, FAAAAI

PubMed

• 5 citations
  Anaphylaxis: Advances in the Past 10 Years.
  Catherine R Weiler, Rik Schrijvers, David B K Golden
  The Journal of Allergy and Clinical Immunology. in Practice. 2023-01-01
• 1 citations
  How Good Are Mast Cell Mediators
  Catherine R. Weiler
  Annals of Allergy, Asthma & Immunology. 2021-07-22
• 8 citations
  Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference
  Jason Gotlib, Tracy I. George, Melody C. Carter, K. Frank Austen, Bruce S. Bochner
  The Journal of Allergy and Clinical Immunology. 2021-06-01

Journal Articles

• Treatment of hypereosinophilic syndromes--the first 100 years  
  Butterfield JH, Weiler CR, Semin Hematol, 1/1/2012
• Anisakis simplex and cross-reacting antigens  
  Weiler CR, The International Society of Dermatology, 1/1/2006
• Subcutaneous Immunoglobulin Therapy  
  Weiler CR, Department of Medicine Intramural Newsletter, 1/1/2003
• Hivers: Skin eruptions usually more irritating than serious  
  Weiler CR, Women's HealthSource Mayo Cilnic, 1/1/2001
• Diagnosing and managing eosinophilic pulmonary disorders  
  Weiler C, Li JTC, J Respir Dis, 1/1/1998
• The use of neuromuscular blocking drugs in the intensive care unit: a US perspective  
  Murray MJ, Strickland RA, Weiler C, Intensive Care Med., 1/1/1993
• Eosinophil activation and function in health and disease  
  Abu-Ghazaleh RI, Kita H, Gleich GJ., Immunol Ser., 1/1/1992
• Interaction of eosinophil granule major basic protein with synthetic lipid bilayers: a mechanism for toxicity  
  Abu-Ghazaleh RI, Gleich GJ, Prendergast FG, J Membr Biol., 1/1/1992
• Eosinophil granule proteins in peripheral blood granulocytes  
  Abu-Ghazaleh RI, Dunnette SL, Loegering DA, Checkel JL, Kita H, Thomas LL, Gleich GJ, J Leukoc Biol, 1/1/1992
• Effect of steroids on immunoglobulin-induced eosinophil degranulation  
  Kita H, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ, J Allergy Clin Immunol, 1/1/1991
• Update on eosinophils  
  Gleich GJ, Abu-Ghazaleh R, Allergy Proc, 1/1/1989
• Update on eosinophils  
  Gleich GJ, Abu-Ghazaleh RI., N Engl Reg Allergy Proc, 1/1/1989
• Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils  
  Kita H, Abu-Ghazaleh RI, Sur S, Gleich GJ, J Immunol, 1/1./1995
• Release of granule proteins from eosinophils cultured with IL-5  
  Kita H, Weiler DA, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ, J Immunol, 1/15/1992
• Role of pertussis toxin-sensitive G proteins in stimulusdependent human eosinophil degranulation  
  Kita H, Abu-Ghazaleh RI, Gleich GJ, Abraham RT, J Immunol, 1/15/1991
• Regulation of Ig-induced eosinophil degranulation by adenosine 3',5'-cyclic monophosphate  
  Kita H, Abu-Ghazaleh RI, Gleich GJ, Abraham RT, J Immunol, 1/15/1991
• Regulatory effect of cytokines on eosinophil degranulation  
  Fujisawa T, Abu-Ghazaleh R, Kita H, Sanderson CJ, Gleich GJ, J Immunol., 1/15/1990
• IgA-induced eosinophil degranulation  
  Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ, J Immunol., 1/1./1989
• Join now to see all

Books/Book Chapters

• Middleton's Allergy Principles and Practice 
  Chapter: Protease-activated pathways of inflammation 
  Page 523.0 - 435.0Kita H, Reed CE, Weiler CREditors: Adkinson NF, Bochner BS, Busse WW, Holgate ST, Lemanske RF, Simmons FER.Elsevier, MosbyEdition 7th,2008
• Textbook of complementary and alternative medicine 
  Chapter: Asthma 
  Page 441.0 - 448.0Weiler CREditors: Yuan CS, Bieber EJ, Bauer BA.Informa Healthcare, AbingdonEdition 2.0,2006
• Immunology 
  Chapter: Clinical Characteristics of Patients with a Diagnosis of Complement Deficiency Evaluated at a Tertiary Referral Center 
  Page 517.0 - 520.0Chenworth E, Butterfield J, Weiler CMedimond2004
• Eosinophils in Allergy and Inflammation 
  Chapter: Eosinophil granule proteins: Structure and function 
  Page 1.0 - 20.0Gleich GJ, Glitz DG, Abu-Ghazaleh RIEditors: G.J. Gleich, A.B. Kay.Marcel Dekker Inc, New York1993
• Granulocyte Responses to Cytokines: Basic and Clinical Research 
  Chapter: Eosinophil activation and function in health and disease 
  Page 137.0 - 167.0Abu-Ghazaleh RI, Kita H, Gleich GJEditors: Ronald G. Coffey.Marcel Dekker Inc, New York1992
• Join now to see all

Abstracts/Posters

• Initial Clinical Presentations of Patients with Hypereosinophilic Syndrome at a Tertiary Medical Center
  Weiler CR, Biennial IES, 1/1/2017
• Hypereosinophilic Syndrome
  Weiler CR, Allergy conference, Rochester, Minnesota, 1/1/2017
• Mastocytosis to MCAS
  Weiler CR, Pennsylvania Allergy Society Meeting, 1/1/2017
• Eosinophilia and Hypereosinophilic Syndrome
  Weiler CR, Pennsylvania Allergy Society Meeting, 1/1/2017
• Differences between patients with systemic mastocytosis (sm) and patients with mast cell activation syndrome (mcas)
  Weiler C, Alhurani RE, Allergy, 1/1/2016
• Mast cells, eosinophils and eosinophilic esophagitis
  Jin J, Alexander J, Kita H, Squillace D, Murray JA, Arora A, Romero Y, Smyrk T, Weiler CR., J Allergy Clin Immunol, 1/1/2014
• A case report of bradykinin receptor antagonist use in idiopathic non-histaminergic angioedema
  Weiler CR, AAAAI, 1/1/2013
• Systemic mastocytosis in the elderly
  Butterfield JH, Weiler CR, J Allergy Clin Immunol, 1/1/2013
• Mast cell activation syndrome associated with elevation in serum tryptase or 24-hour urine 11 beta-prostaglandin- f-2 alpha
  Ravi A, Butterfield JH, Weiler CR, J Allergy Clin Immunol, 1/1/2013
• Hypereosinophilic syndrome and thrombosis: a retrospective review
  Wallace KL, Elias MK, Butterfield JH, Weiler CR, J Allergy Clin Immunol, 1/1/2013
• Mast cell activation disorder associated with elevation in serum tryptase or urinary 11 beta prostaglandin F2a
  Weiler CR, AAAAI, 1/1/2012
• Venom allergy in systemic mastocytosis
  Sridhara S, Weiler C, Butterfield J., J Allergy Clin Immunol, 1/1/2012
• Whole blood serotonin levels in cutaneous mastocytosis, systemic mastocytosis and mast cell activation syndrome
  Butterfield J, Weiler C, J Allergy Clin Immunol, 1/1/2011
• Systemic Mastocytosis: Mayo Clinic experience since 2000
  Sridhara S, Butterfield JH, Weiler CR., J Allergy Clin Immunol, 1/1/2011
• Melkersson-rosenthal syndrome and its variants- the Mayo Clinic experience
  Elias MK, Weiler CR, J Allergy Clin Immunol, 1/1/2010
• Clinical course of eosinophilic gastrointestinal diseases (EGID) with and without eosinophilia: a retrospective case review.
  Lee J, Weiler CR, Alexander JA, J Allergy Clin Immunol, 1/1/2010
• Eosinophilic esophagitis in adults lacks seasonal correlation
  Karakelides M, Kopacova J, Enders F, Dierkhising R, Talley N, Weiler C, Alexander J, Am J Gastroenterol, 1/1/2009
• Non-corticosteroid eosinophil-lowering agents for treatment of eosinophilic gastrointestinal disorders (EGIDs)
  Lee J, Butterfield JH, Alexander J, Weiler CR, J Allergy Clin Immunol, 1/1/2009
• Eosinophil degranulation, gastric eosinophil-derived neurotoxin (gEDN) levels and dysphagia score in patients with eosinophilic Esophagitis (EE)
  Weiler CR, Squillace D, Kephart G, Romero Y, Alexander J, Kita H., J Allergy Clin Immunol, 1/1/2008
• The use of danazol in the management of refractory chronic urticaria
  Karakelides M, Weiler CR, J Allergy Clin Immunol, 1/1/2007
• Monoclonal gammopathies and malignancies in patients with chronic urticaria.
  Karakelides M, Volcheck G, Weiler C, Clin Immunol, 1/1/2006
• Clinical and Laboratory Findings in Twenty Eight Patients with Primary Immunoglobulin Deficiency Associated with Lymphadenopathy, Hepatosplenomegaly and Pulmonary Infi...
  Weiler CR, Clinical Immunology Society, Boston, Massachusetts, 1/1/2005
• Subcutaneous immunoglobulin (SCIG) therapy: review of 51 patients
  Kirmse J, Weiler CR, J Allergy Clin Immunol, 1/1/2005
• Specific polysaccharide antiboy deficiency syndrome (SPAD): clinical and laboratory characteristics of seventy seven patients
  Cheng YK, Decker PA, O'Byrne MM, Weiler CR, J Allergy Clin Immunol, 1/1/2005
• Comparison of an in-house preparation of the major allergenic determinant of benzyl penicillin G with the commercially produced Pre-Pen
  Matesic D, Frigas E, Harris PA, Volcheck GW, Markus PA, Weiler CR, Maddox DE, Li JTC, Van Dellen RG, Hagan JB, Butterfield JH, J Allergy Clin Immunol, 1/1/2005
• Join now to see all

Lectures

• Urinary Tests for Mast Cell Mediators: Why Order Them? 
  Orlando, Florida - 1/1/2018
• Spells: Spectrum from Idiopathic Anaphylaxis to Systemic Mastocytosis 
  1/1/2018
• Mast Cell Activation Syndrome (MCAS): Real or Myth? 
  1/1/2018
• High Tryptase: When is it Time for a Bone Marrow Biopsy? 
  Orlando, Florida - 1/1/2018
• Anaphylaxis to Mastocytosis 
  1/1/2017
• Differences between Patients with Systemic Mastocytosis (SM) and Patients with Mast Cell Activation Syndrome (MCAS) 
  Vienna, Austria - 1/1/2016
• Common Variable Immune Deficiency and Gastrointestinal Tract. 
  Chicago, Illinois - 1/1/2005
• Clinical and Laboratory Findings in Twenty Eight Patients with Primary Immunoglobulin Deficiency Associated with Lymphadenopathy, Hepatosplenomegaly, and Pulmonary Inf... 
  1/1/2005
• What's New in Asthma Drugs. 
  1/1/2004
• Management of Bronchial Asthma 
  1/1/2004
• Hypogammaglobulinemia and Adenopathy: Common Variable Immune Deficiency, HyperIgM Syndrome, and Autoimmune Lymphoproliferative Syndrome 
  1/1/2004
• Chronic Urticaria and MGUS 
  Denver, Colorado - 1/1/2003
• Subcutaneous Immunoglobulin Therapy: Rationale, Indications, Technique, Risk and Benefit 
  1/1/2003
• Clinical Review for Internal Medicine Physicians--Allergic Rhinitis and Asthma 
  1/1/2003
• Intranasal Influenza Vaccination: FluMist 
  1/1/2003
• Malabsorption and Primary Immune Deficiency 
  1/1/2003
• IVIG vs SCIG, Indications, risks and Benefits 
  Mayo Clinic, Rochester, Minnesota - 1/1/2002
• Clinical Reviews: What's New in Asthma and Allergies 
  1/1/2002
• Clinical Review for Outreach Physicians: The ARIA Initiative (allergic rhinitis and its impact on asthma) 
  Decorah, Iowa - 1/1/2002
• Physical Exam for First Year Medical Students 
  Mayo Medical School, Rochester, Minnesota - 1/1/2001
• Cockroach Allergen-induced Eosinophilic Airway Inflammation in HLA-DQ/human CD4+ Transgenic Mice 
  1/1/2001
• Chronic Urticaria: Diagnosis and Therapy Date 
  Mayo - 1/1/2001
• Chronic Urticaria and Angioedema, Clinical Presentation and Management Options 
  1/1/2001
• Monoclonal Gammopathies of Undetermined Significance (MGUS) Associated with Urticaria and Angioedema 
  1/1/2001
• Therapeutic Protocol for Patients with Chronic Urticaria 
  1/1/2001
• Join now to see all

Other

• The Immune System in Health and Disease (local radio talk show) 
  KROC Healthline
  Rochester, Minnesota - 1/1/2002
• Study of the immunoglobulin signals inducing eosinophil degranulation 
  Abu-Ghazaleh RI, Mayo Graduate School
  1/1/1989